Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 39 years old at the time of your cancer diagnosis
- You have been diagnosed with a confirmed cancer, which may include leukemia, Hodgkin or non-Hodgkin lymphoma, testicular cancer, osteosarcoma, Ewing sarcoma, breast cancer, or cervical cancer
- You are about to start treatment aimed at curing your cancer, which may include surgery, radiotherapy, chemotherapy, or antibody-based treatments (either at the same time or one after another)
Who may not be able to join:
- You are not able to read or understand the trial information and consent forms
- You are going to be treated with a type of cancer drug called immune checkpoint inhibitors, or with drugs that target blood vessel growth (anti-angiogenesis therapy) (confirm with trial site)
- You have previously been treated with systemic (whole-body) cancer therapy or radiotherapy for a past cancer — though exceptions may apply if your previous cancer was an early-stage cervical or uterine cancer, or a common type of skin cancer that was fully treated
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: J. Nuver, MD, PhD, University Medical Center Groningen
Phone: +31 50 361 2821
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in senescence marker P16
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.